$GLMD

Galmed Pharmaceuticals Ltd

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Other
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.5 ▲3.627%

Extented Hours

VOLUME

21,890

DAY RANGE

0.46 - 0.5

52 WEEK

0.4167 - 3.42

Join Discuss about GLMD with like-minded investors

profile
@dros #droscrew
recently

Upgrades 5/3: $API $ARGX $FIBK $IDA $JAKK $JPM $KOF $LIN $MHK $MMC $MS $SHEN $SIVB $SNDL $TCBK $VRTX . Downgrades 5/3: $AI $CHGG $CHTR $CL $CNP $CVNA $DOCU $ED $EVER $GLMD $K $MTTR $NYCB $PAC $PLAN $SFT $TSN

128 Replies 15 👍 8 🔥

Key Metrics

Market Cap

12.39 M

Beta

0.95

Avg. Volume

87.43 K

Shares Outstanding

25.09 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.It is also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study by the first quarter of 2021.

CEO: Allen Baharaff

Website:

HQ: 16 Zeev Tyomkin St 4th Fl, 6578317 Tel Aviv Yafo

Related News